Seeing Is Believing
Currently out of the existing stock ratings of Salveen Richter, 116 are a HOLD (35.47%), 189 are a BUY (57.8%), 22 are a SELL (6.73%).
Analyst Salveen Richter, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 61.83% that have a potential upside of 33.84% achieved within 255 days.
Salveen Richter’s has documented 629 price targets and ratings displayed on 50 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on FDMT, 4D Molecular Therapeutics at 09-May-2025.
Analyst best performing recommendations are on ALLO (ALLOGENE THERAPEUTICS).
The best stock recommendation documented was for ALLO (ALLOGENE THERAPEUTICS) at 10/7/2021. The price target of $20 was fulfilled within 1 day with a profit of $4.38 (17.97%) receiving and performance score of 179.66.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$35
$13.43 (62.26%)
$23
14 days ago
(21-May-2025)
0/4 (0%)
$13.15 (60.18%)
Hold
$24
$2.43 (11.27%)
$20
15 days ago
(20-May-2025)
17/22 (77.27%)
$2.31 (10.65%)
166
Buy
$31
$9.43 (43.72%)
$28
16 days ago
(19-May-2025)
0/4 (0%)
$9.01 (40.97%)
Hold
$23
$1.43 (6.63%)
$20
16 days ago
(19-May-2025)
8/12 (66.67%)
$1.01 (4.59%)
184
Buy
$32
$10.43 (48.35%)
$27
16 days ago
(19-May-2025)
7/22 (31.82%)
$10.01 (45.52%)
118
Which stock is Salveen Richter is most bullish on?
Which stock is Salveen Richter is most reserved on?
What Year was the first public recommendation made by Salveen Richter?